Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bygdeman

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Contraception|January 1, 1989
Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486E Johannisson, M Oberholzer, M L Swahn, et al.
Contraception|May 1, 1975
Early second trimester abortion by the extra-amniotic instillation of Rivanol solution and a single PGF2alpha doseJ N Martin, M Bygdeman, A Leader, et al.
Steroids|December 8, 2000
Pregnancy terminationM Bygdeman, K Gemzell Danielsson, L Marions, et al.
Prostaglandins|February 1, 1975
Prostaglandin analogues and uterotonic potency: a comparative study of seven compoundsN Wiqvist, J N Martin, M Bygdeman, et al.
Neuroreport|November 21, 1994
Peripherally grafted human foetal dorsal root ganglion cells extend axons into the spinal cord of adult host rats by circumventing dorsal root entry zone astrocytesE N Kozlova, I Strömberg, M Bygdeman, et al.
Sexually Transmitted Diseases|October 1, 1984
Susceptibility of Neisseria gonorrhoeae to rifampicin and thiamphenicol: correlation with protein I antigenic determinantsS M Bygdeman, P A Mårdh, E G Sandström
Annals of the New York Academy of Sciences|January 1, 1991
Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implicationsM Bygdeman, K Gemzell, C Gottlieb, et al.
Contraception|May 1, 1990
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancyM L Swahn, C Gottlieb, K Green, et al.
Contraception|July 1, 1981
Self-administration of prostaglandin for termination of early pregnancyM Bygdeman, N J Christensen, K Gréen, et al.
Genitourinary Medicine|June 1, 1987
Serological ecology of Neisseria gonorrhoeae (PPNG and non-PPNG) strains: Canadian perspectiveJ R Dillon, S M Bygdeman, E G Sandström
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Contraception|January 1, 1989
Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486E Johannisson, M Oberholzer, M L Swahn, et al.
Contraception|May 1, 1975
Early second trimester abortion by the extra-amniotic instillation of Rivanol solution and a single PGF2alpha doseJ N Martin, M Bygdeman, A Leader, et al.
Steroids|December 8, 2000
Pregnancy terminationM Bygdeman, K Gemzell Danielsson, L Marions, et al.
Prostaglandins|February 1, 1975
Prostaglandin analogues and uterotonic potency: a comparative study of seven compoundsN Wiqvist, J N Martin, M Bygdeman, et al.
Neuroreport|November 21, 1994
Peripherally grafted human foetal dorsal root ganglion cells extend axons into the spinal cord of adult host rats by circumventing dorsal root entry zone astrocytesE N Kozlova, I Strömberg, M Bygdeman, et al.
Sexually Transmitted Diseases|October 1, 1984
Susceptibility of Neisseria gonorrhoeae to rifampicin and thiamphenicol: correlation with protein I antigenic determinantsS M Bygdeman, P A Mårdh, E G Sandström
Annals of the New York Academy of Sciences|January 1, 1991
Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implicationsM Bygdeman, K Gemzell, C Gottlieb, et al.
Contraception|May 1, 1990
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancyM L Swahn, C Gottlieb, K Green, et al.
Contraception|July 1, 1981
Self-administration of prostaglandin for termination of early pregnancyM Bygdeman, N J Christensen, K Gréen, et al.
Genitourinary Medicine|June 1, 1987
Serological ecology of Neisseria gonorrhoeae (PPNG and non-PPNG) strains: Canadian perspectiveJ R Dillon, S M Bygdeman, E G Sandström
Pageof 28